ASTA

KOSDAQ-246720
KOSDAQ
Laboratory Analytical Instruments
Global Rank
#26731
Country Rank
#1258
Market Cap
82.96 M
Price
5.66
Change (%)
0.60%
Volume
15,161

ASTA's latest marketcap:

82.96 M

As of 11/13/2025, ASTA's market capitalization has reached $82.96 M. According to our data, ASTA is the 26731th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 82.96 M
Revenue (ttm) 2.31 M
Net Income (ttm) -1,964,071.88
Shares Out 14.91 M
EPS (ttm) -0.15
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 11/13/2025

ASTA's yearly market capitalization.

ASTA has seen its market value drop from ₩186.17 B to ₩121.56 B since 2017, representing a total decrease of 34.71% and an annual compound decline rate (CAGR) of 5.27%.
Date Market Cap(₩) Market Cap(USD) Change (%) Global Rank
11/13/2025 ₩121.56 B $82.96 M 102.01% 26731
12/30/2024 ₩63.49 B $42.54 M -21.31% 29115
12/28/2023 ₩80.69 B $62.13 M 58.71% 26328
12/29/2022 ₩50.84 B $40.17 M -14.68% 28363
12/30/2021 ₩59.59 B $50.05 M 2.27% 27536
12/30/2020 ₩58.27 B $53.61 M 4.41% 24310
12/30/2019 ₩55.81 B $47.99 M -41.87% 22150
12/28/2018 ₩95.99 B $85.43 M -48.44% 18068
12/28/2017 ₩186.17 B $173.14 M 15250

Company Profile

ASTA Corporation Overview

ASTA Corporation is a South Korean company specializing in the development of advanced diagnostic solutions. Founded in 2006 and headquartered in Suwon-si, the company focuses on innovative technologies for rapid disease diagnosis and bioanalysis.

Key Products and Solutions

  • Microorganism Identification Systems:
    • MicroIDSys & MicroIDSys Elite – Used for infectious disease diagnosis, food hygiene management, agriculture/livestock quarantine, and bio-terrorism prevention.
  • MALDI-TOF Mass Spectrometry Solutions:
    • IDSys LT/RT – A high-performance diagnostic tool.
  • Specialized Diagnostic Systems:
    • NosIDSys – An economical system for detecting rare diseases like cancer and degenerative brain disorders.
  • OLED Analysis & Testing:
    • OASys – A laser desorption ionization time-of-flight mass spectrometer for OLED applications.
  • Supporting Products:
    • MALDI Plate – A disposable plate for diagnostics.
    • Rapid Enzyme Digestion System – Enhances analytical efficiency.

Additionally, ASTA Corporation develops proprietary diagnostics software to complement its hardware solutions, ensuring comprehensive and accurate results.

Frequently Asked Questions

  • What is ASTA's (KOSDAQ-246720) current market cap?
    As of 11/13/2025, ASTA (including the parent company, if applicable) has an estimated market capitalization of $82.96 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • ASTA global market capitalization ranking is approximately 26731 as of 11/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.